AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.

AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
复制标题

DOI:
10.1016/j.juro.2017.04.101
复制
发表时间:
2017-10
期刊:
The Journal of urology
影响因子:
--
通讯作者:
Eggener S
Eggener S
中科院分区:
其他
文献类型:
--
作者:
Fulgham PF;Rukstalis DB;Turkbey IB;Rubenstein JN;Taneja S;Carroll PR;Pinto PA;Bjurlin MA;Eggener S

文献摘要

参考文献

被引文献

相似文献

我们总结了磁共振成像在前列腺癌诊断和治疗中的临床和经济有效性的现有数据,并为其在前列腺癌的筛查、诊断、分期和监测中的应用提供了实用的建议。一组在前列腺癌诊断和治疗方面具有专业知识的临床医生评估了目前发表的关于磁共振成像在这种疾病中的使用和有效性的文献。当有足够的研究供分析时,就根据数据提出建议;当没有足够的研究时,就根据专家共识提出建议。目前的数据支持在既往活检呈阴性的患者中使用磁共振成像,并持续担心前列腺癌风险增加。有关其对初始活检有用性的数据表明,在某些情况下,磁共振成像可能起作用。目前没有足够的证据推荐磁共振成像用于前列腺癌的筛查、分期或监测。虽然它增加了前列腺癌治疗的成本,但磁共振成像提供了优越的解剖细节,以及基于水扩散和基于对比度增强的血流来评估细胞密度的能力。成像靶向活检可以通过识别常规超声不可见的特定病变来增加临床重要癌症的诊断。磁共振成像在前列腺癌治疗中的临床适应症正在迅速发展。
We summarize the available data about the clinical and economic effectiveness of magnetic resonance imaging in the diagnosis and management of prostate cancer, and provide practical recommendations for its use in the screening, diagnosis, staging and surveillance of prostate cancer. A panel of clinicians with expertise in the diagnosis and management of prostate cancer evaluated the current published literature on the use and effectiveness of magnetic resonance imaging for this disease. When adequate studies were available for analysis, recommendations were made on the basis of data and when adequate studies were not available, recommendations were made on the basis of expert consensus. At this time the data support the use of magnetic resonance imaging in patients with a previous negative biopsy and ongoing concerns about increased risk of prostate cancer. The data regarding its usefulness for initial biopsy suggest a possible role for magnetic resonance imaging in some circumstances. There is currently insufficient evidence to recommend magnetic resonance imaging for screening, staging or surveillance of prostate cancer. Although it adds cost to the management of prostate cancer, magnetic resonance imaging offers superior anatomic detail, and the ability to evaluate cellular density based on water diffusion and blood flow based on contrast enhancement. Imaging targeted biopsy may increase the diagnosis of clinically significant cancers by identifying specific lesions not visible on conventional ultrasound. The clinical indications for the use of magnetic resonance imaging in the management of prostate cancer are rapidly evolving.
DOI: 10.1002/jmri.25372
发表时间: 2017-03
期刊: Journal of magnetic resonance imaging : JMRI
影响因子: --
作者:
Greer MD;Brown AM;Shih JH;Summers RM;Marko J;Law YM;Sankineni S;George AK;Merino MJ;Pinto PA;Choyke PL;Turkbey B
通讯作者: Turkbey B
DOI: 10.1016/j.eururo.2014.03.002
发表时间: 2014-07-01
期刊: EUROPEAN UROLOGY
影响因子: 23.4
作者:
Pokorny, Morgan R.;De Rooij, Maarten;Thompson, Leslie C.
通讯作者: Thompson, Leslie C.
DOI: 10.1016/j.ejrad.2013.04.041
发表时间: 2013-10-01
影响因子: 3.3
作者:
Mazaheri, Yousef;Vargas, H. Alberto;Hricak, Hedvig
通讯作者: Hricak, Hedvig
DOI: 10.1097/coc.0b013e31829a2954
发表时间: 2015-06-01
影响因子: 2.6
作者:
Bittner, Nathan;Merrick, Gregory S.;Adamovich, Edward
通讯作者: Adamovich, Edward
DOI: 10.1016/j.urolonc.2013.08.006
发表时间: 2014-08
期刊: Urologic oncology
影响因子: --
作者:
Sonn GA;Margolis DJ;Marks LS
通讯作者: Marks LS